County
Brunswick County EMS
Drugs and doses58
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate, Casirivimab, Ceftriaxone, Clonidine13
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV | not captured | standing | pages 27, 344 |
| Fever | adult | 325–1000 mg | PO | not captured | standing | pages 27, 344 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | pages 27, 344 |
| Fever | peds | 15 mg/kg | IV | not captured | standing | pages 27, 344 |
| Other | adult | 500–1000 mg | PO | not captured | standing | page 195 |
| Other | adult | 1000 mg | IV/IO | not captured | standing | page 344 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | page 344 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | pages 28, 344 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | pages 28, 344 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 28, 344 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | pages 28, 344 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | pages 173, 344 |
| Other | peds | 1 g/kg | PO | not captured | standing | pages 173, 344 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV/IO | not captured | standing | pages 79, 80, 344 |
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 79, 80, 146, 148, 344 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 79, 80, 146, 148, 344 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5–5 mg | NEB | not captured | standing | pages 102, 154, 345 |
| Other | peds | 2.5–5 mg | NEB | not captured | standing | pages 102, 154, 345 |
| Respiratory distress | adult | 2.5–5 mg | NEB | not captured | standing | pages 54, 60, 154, 345 |
| Respiratory distress | peds | 1.25–2.5 mg | NEB | not captured | standing | pages 54, 60, 154, 345 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 79, 340, 345 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 81, 345 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 85, 150, 151, 345 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 85, 150, 151, 345 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 75, 345 |
| Mild to moderate pain | adult | 324–650 mg | PO | not captured | standing | pages 28, 345 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 71, 141, 346 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 71, 141, 346 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | pages 175, 176 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | pages 141, 346 |
| Other | peds | 0.5 mg | IV/IO/IM | not captured | standing | pages 176, 346 |
| Other | peds | 1 mg | IV/IO/IM | not captured | standing | pages 176, 346 |
| Other | peds | 2 mg | IV/IO/IM | not captured | standing | pages 176, 346 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | pages 193, 195 |
| Other | adult | 8 mg | SL | not captured | standing | page 194 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | pages 106, 125, 173 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 106, 125 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | pages 106, 125 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | pages 173, 346 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | pages 173, 346 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 173, 346 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 173, 346 |
| Cardiac arrest | adult | 2 g | IV/IO | not captured | standing | pages 106, 346 |
| Cardiac arrest | peds | 30 mg/kg | IV/IO | not captured | standing | pages 106, 346 |
| Crush injury | adult | 2 g | IV/IO | not captured | standing | pages 125, 346 |
| Crush injury | peds | 20 mg/kg | IV/IO | not captured | standing | pages 125, 346 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | pages 106, 125, 173, 346 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 160 |
| Hyperkalemia | peds | 30 mg/kg | IV/IO | not captured | standing | pages 106, 125, 160, 173, 346 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 106, 125 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 113, 114, 160, 161, 346 |
| Other | peds | 30 mg/kg | IV/IO | not captured | standing | pages 106, 125 |
| Other | peds | 30 mg/kg | IV/IO | not captured | standing | pages 113, 114, 160, 161, 346 |
Casirivimab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IV | not captured | standing | page 188 |
| Other | adult | 600 mg | SQ | not captured | standing | page 188 |
| Other | adult | 600 mg | IV | not captured | standing | page 188 |
| Other | adult | 600 mg | SQ | not captured | standing | page 188 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mg/kg | IV/IO | not captured | standing | pages 36, 37 |
| Sepsis | adult | 50 mg/kg | IV/IO | not captured | standing | pages 36, 37 |
| Sepsis | peds | 50 mg/kg | IV/IO | not captured | standing | pages 36, 37 |
| Trauma / hemorrhage | adult | 50 mg/kg | IV/IO | not captured | standing | pages 127, 357 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV/IO | not captured | standing | pages 127, 357 |
Clonidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg | PO | not captured | standing | pages 193, 194, 195 |
| Other | adult | 0.1 mg | PO | not captured | standing | pages 193, 194, 195 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Famotidine, Fentanyl, Furosemide11
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Allergic reaction | peds | 5 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Asthma / bronchospasm | adult | 10 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Asthma / bronchospasm | peds | 5 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| COPD | adult | 10 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| COPD | peds | 5 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Croup | adult | 10 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Croup | peds | 5 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Other | adult | 4 mg | IV/IO/IM | not captured | standing | page 346 |
| Other | peds | 10 mg | IV/IO/IM | not captured | standing | page 159 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 125 mL | IV/IO | not captured | standing | pages 104, 156, 157, 347 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 104, 156, 157, 347 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | pages 117, 118 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IO | not captured | standing | page 43 |
| Hyperactive delirium | adult | 5 mg | IV/IO | not captured | standing | page 44 |
| Other | adult | 10 mg | PR | not captured | standing | page 163 |
| Other | adult | 4 mg | IV/IO | not captured | standing | page 163 |
| Other | adult | 5 mg/kg | IV/IO/PR | not captured | standing | page 125 |
| Other | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 163 |
| Other | peds | 0.1 mg/kg | IV/IO/PR | not captured | standing | page 125 |
| Seizure | adult | 10 mg | PR | not captured | standing | page 32 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 32 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 32 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 32 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–15 mg | IV/IO | not captured | standing | page 79 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 79, 80, 340, 347 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | pages 102, 154 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 102, 154 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | pages 102, 154 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 102, 154 |
| Dystonic reaction | adult | 25–50 mg | IV/IM/PO | not captured | standing | page 15 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 41 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 41 |
| Other | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | page 102 |
| Other | adult | 25–50 mg | not captured | not captured | standing | page 15 |
| Other | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | page 347 |
| Other | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 154 |
| Other | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 347 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 348 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.05 mcg/kg | IV/IO | not captured | standing | pages 102, 103, 154, 155 |
| Allergic reaction | adult | 0.3–0.5 mg | IM | not captured | standing | pages 102, 103, 154, 155, 348 |
| Allergic reaction | peds | 0.15 mg | IM | not captured | standing | pages 102, 103, 154, 155, 348 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | pages 71, 72, 141, 142, 348 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 71, 72, 141, 142, 348 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 69, 70, 85, 86, 139, 140, 144, 145, 150, 151, 348 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 69, 70, 85, 86, 139, 140, 144, 145, 150, 151, 348 |
| COPD | adult | 1 mg | NEB | not captured | standing | pages 54, 60, 348 |
| COPD | peds | 1 mg | NEB | not captured | standing | pages 54, 60, 348 |
| Hypotension / shock | peds | 0.05 mcg/kg | IV/IO | not captured | standing | pages 36, 109, 158, 348 |
| Hypotension / shock | peds | 0.05 mcg/kg | IV/IO | not captured | standing | pages 36, 109, 158, 348 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | pages 60, 348 |
| Other | peds | 0.3–0.5 mg | IM | not captured | standing | pages 154, 348 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 52, 349 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20 mg | IV/PO | not captured | standing | pages 102, 154 |
| Allergic reaction | peds | 20 mg | IV/PO | not captured | standing | pages 102, 154 |
| Other | peds | 20 mg/kg | IV/PO | not captured | standing | page 154 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50–75 mcg | IV/IO | not captured | standing | pages 75, 349 |
| Other | adult | 100 mcg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 25 mcg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 50–100 mcg | IV/IO | not captured | standing | pages 62, 349 |
| Other | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | pages 28, 349 |
| Other | adult | 50 mcg | IV/IM/SQ | not captured | standing | page 186 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 62, 349 |
| Other | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 28, 349 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | pages 28, 349 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 28, 349 |
| Post-intubation sedation | adult | 50–100 mcg | IV/IO | not captured | standing | pages 62, 349 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 62, 349 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | pages 77, 349 |
| Other | adult | 40 mg | IV/IO | not captured | standing | page 97 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 143 |
G–L Glucagon, Haloperidol, Heparin, Hydrocortisone, Hydromorphone, Hydroxocobalamin, Ibuprofen, Imdevimab, Ipratropium, Ketamine, Ketorolac, Levetiracetam, Lidocaine, Loperamide, Lorazepam15
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | pages 173, 350 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 173, 350 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | pages 104, 156 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 104, 156 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | pages 156, 350 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IM | not captured | standing | pages 43, 350 |
| Agitation | peds | 1–5 mg | IM | not captured | standing | pages 43, 350 |
| Other | adult | 2 mg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 4 mg | IV/IM/SQ | not captured | standing | page 186 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg | IV/IO | not captured | standing | pages 75, 350 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Other | peds | 100 mg | IV/IO/IM | not captured | standing | page 159 |
| Other | peds | 25 mg | IV/IO/IM | not captured | standing | page 159 |
| Other | peds | 50 mg | IV/IO/IM | not captured | standing | page 159 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 1 mg | IV/IM/SQ | not captured | standing | page 186 |
| Mild to moderate pain | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 186 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 164 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 164 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 27 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 27 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 28 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 28 |
Imdevimab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IV | not captured | standing | page 188 |
| Other | adult | 600 mg | SQ | not captured | standing | page 188 |
| Other | adult | 600 mg | IV | not captured | standing | page 188 |
| Other | adult | 600 mg | SQ | not captured | standing | page 188 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | pages 54, 60, 154, 351 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | pages 54, 60, 154, 351 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | pages 44, 45 |
| Hyperactive delirium | peds | 2 mg/kg | IM | not captured | standing | pages 44, 45 |
| Other | adult | 1–2 mg/kg | IV/IO | not captured | standing | pages 52, 351 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 351 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 28 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 28 |
| Post-intubation sedation | adult | 1.5–2 mg/kg | IV/IO | not captured | standing | page 62 |
| Procedural sedation | adult | 1–2 mg/kg | IV/IO/IM/IN | not captured | standing | page 52 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | pages 28, 352 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | pages 28, 352 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 28, 352 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | pages 28, 352 |
| Severe pain | adult | 15 mg | IV/IO | not captured | standing | pages 28, 352 |
| Severe pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 28, 352 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 1 g | IV/IO | not captured | standing | pages 32, 33 |
| Seizure | peds | 15 mg/kg | IV/IO | not captured | standing | pages 32, 33 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–50 mg | IO | not captured | standing | page 287 |
| Other | adult | 20–50 mg | IO | not captured | standing | page 287 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 287 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 287 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 85, 150, 151, 352 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 85, 150, 352 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 85, 150, 151, 352 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 85, 150, 352 |
Loperamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | PO | not captured | standing | page 195 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg | IV/IO | not captured | standing | page 43 |
| Agitation | adult | 2 mg | IM | not captured | standing | page 43 |
| Hyperactive delirium | adult | 1 mg | IV/IO | not captured | standing | page 44 |
| Hyperactive delirium | adult | 2 mg | IM | not captured | standing | page 44 |
| Other | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 1 mg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 163 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 163 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | page 32 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 147 |
| Seizure | adult | 1 mg | IV/IO | not captured | standing | pages 32, 33 |
| Seizure | adult | 2 mg | IM | not captured | standing | pages 32, 33 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 32, 33 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | pages 32, 33 |
| Narrow-complex tachycardia | adult | 1 mg | IV/IO | not captured | standing | page 81 |
| Narrow-complex tachycardia | adult | 2 mg | IM | not captured | standing | page 81 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oxymetazoline, Oxytocin10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–4 g | IV/IO | not captured | standing | pages 119, 353 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 85, 353 |
| Other | adult | 5–10 g | IM | not captured | standing | page 353 |
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | pages 54, 60, 61 |
| Respiratory distress | peds | 40 mg/kg | IV/IO | not captured | standing | pages 54, 60, 61 |
| Seizure | adult | 2 g | IV/IO | not captured | standing | page 33 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 83, 85 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 110, 159 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 102 |
| Other | peds | 2 mg/kg | IV | not captured | standing | pages 154, 353 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | pages 54, 60, 102, 154, 158, 353 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 54, 60, 102, 154, 158, 353 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | pages 79, 342, 354 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 43 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 43 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 43 |
| Bradycardia | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 71 |
| Hyperactive delirium | adult | 10 mg | IM | not captured | standing | pages 44, 45 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | pages 44, 45 |
| Other | adult | 0.2 mg/kg | IM | not captured | standing | pages 32, 33 |
| Other | adult | 2–2.5 mg | IV/IO | not captured | standing | page 119 |
| Other | adult | 2–2.5 mg | IV | not captured | standing | page 45 |
| Other | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 43 |
| Other | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 43 |
| Other | peds | 0.2 mg/kg | IM | not captured | standing | pages 32, 33 |
| Post-intubation sedation | adult | 2–2.5 mg | IV/IO | not captured | standing | page 62 |
| Post-intubation sedation | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 62 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 32, 33 |
| Seizure | adult | 2–2.5 mg | IV/IO | not captured | standing | pages 32, 33 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 32, 33 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 32, 33 |
| Narrow-complex tachycardia | adult | 2–2.5 mg | IV/IO | not captured | standing | page 79 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg | IV/IM/SQ | not captured | standing | page 186 |
| Other | adult | 4 mg | IV/IO | not captured | standing | page 62 |
| Other | adult | 4 mg | IV/IM/SQ | not captured | standing | page 186 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 62 |
| Mild to moderate pain | adult | 4 mg | IV/IO/IM | not captured | standing | pages 28, 75 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 28, 75 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | pages 73, 144, 172 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | pages 73, 144, 172 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 73, 144, 172 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | pages 73, 144, 172 |
| Other | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | page 355 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 355 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 75, 77 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 77 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 75 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 14 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 14 |
| Other | adult | 4 mg | IV/IM | not captured | standing | page 186 |
| Other | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 356 |
| Other | adult | 4 mg | not captured | not captured | standing | page 194 |
| Other | peds | 0.2 mg/kg | PO/ODT | not captured | standing | page 356 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 25 |
| Other | adult | 2 spray | not captured | not captured | standing | page 356 |
| Other | adult | 2 spray | IN | not captured | standing | page 25 |
| Other | peds | 2 spray | not captured | not captured | standing | page 356 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | pages 115, 116, 119 |
| Obstetric hemorrhage | adult | 10 unit | IV/IO | not captured | standing | page 116 |
| Other | adult | 10 unit | IM | not captured | standing | pages 115, 116, 119, 120, 356 |
P–R Pralidoxime, Procainamide, Promethazine, Rocuronium4
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | pages 175, 356 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | pages 175, 356 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | page 149 |
| Wide-complex tachycardia | adult | 20–50 mg | IV/IO | not captured | standing | pages 81, 357 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IM/PO | not captured | standing | pages 14, 15 |
| Other | adult | 12.5 mg | IV/IM | not captured | standing | page 357 |
| Other | adult | 25 mg | IV/IM | not captured | standing | page 186 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.6–1.2 mg/kg | IV/IO | not captured | standing | page 62 |
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 52 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 357 |
S–Z Sodium Bicarbonate, Succinylcholine, Terbutaline, Tranexamic Acid, Whole Blood5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mEq | IV/IO | not captured | standing | pages 31, 358 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 31, 358 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | pages 125, 358 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 125, 358 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 106, 125, 173, 358 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 106, 125, 173, 358 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | pages 173, 358 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 173, 358 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 52, 358 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.25 mg | SQ | not captured | standing | page 359 |
| Respiratory distress | peds | 0.01 mg/kg | SQ | not captured | standing | page 359 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | pages 116, 119, 343 |
| Obstetric hemorrhage | peds | 20 mg/kg | IV/IO | not captured | standing | pages 116, 119, 343 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | pages 130, 131, 343, 359 |
| Other | adult | 1 g | TOP | not captured | standing | pages 23, 314, 359 |
| Other | adult | 1 g | TOP | not captured | standing | pages 23, 26, 314, 359 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | pages 116, 120, 343, 359 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 119 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 119 |
| Trauma / hemorrhage | adult | 1 g | TOP | not captured | standing | pages 23, 314, 359 |
| Trauma / hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | pages 130, 131, 343 |
| Trauma / hemorrhage | peds | 20 mg/kg | IV/IO | not captured | standing | pages 130, 131, 343 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | pages 113, 160, 360 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | pages 113, 160, 360 |
Change history2
| Recorded | Change | From | To |
|---|---|---|---|
| 2026-10-31 | superseded | current | superseded |
| 2026-10-31 | added | not captured | listed_named |
Cite this
Brunswick County EMS, United States EMS Protocol Census. 301 dose entries, effective 2026-01-01.
https://protoquiz.com/census/agencies/brunswick-county-ems/
The census is free and not for sale. Only public agencies are named.